International Patent: METHODS OF TREATING CANCER WITH A COMBINATION OF A CANCER VACCINE AND A TAAXCD28 BISPECIFIC ANTIGEN-BINDING MOLECULE

GENEVA, June 24 -- REGENERON PHARMACEUTICALS, INC. filed a patent application (US2025/056953) for “METHODS OF TREATING CANCER WITH A COMBINATION OF A CANCER VACCINE AND A TAAXCD28 BISPECIFIC ANTIGEN-BINDING MOLECULE”. With publication no. WO/2026/117523, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....